Insights on Cannabinoid Clinical Trials for Mental Health and Substance Use
Cannabinoid clinical trials mental health substance use provide evidence on the efficacy and safety of cannabinoids in treating these disorders. This meta-analysis reviews randomized controlled trials assessing cannabinoids as primary treatments. The…
Review of Cannabinoid Clinical Trials for Mental Health Treatment
This cannabinoid clinical trials mental health treatment review summarizes current evidence on cannabinoids' efficacy and safety for mental health disorders. The review highlights consistent adverse effects reported in trials. Careful clinical monitoring…
Cannabinoids for Mental & Substance Use Disorders: Evidence
Current evidence on cannabinoids for substance use disorders shows limited and inconsistent benefits. Safety concerns remain a consistent finding across clinical trials. The efficacy of cannabinoids for mental and substance use disorders remains…
The Impact of Alcohol and Cocaine Misuse on Cognitive Flexibility
Cognitive flexibility alcohol cocaine misuse significantly impacts brain function and decision-making. This article explores the neural pathways affected by these substances. Understanding this impact is crucial for developing effective treatments.
A promising cure for PTSD: Cannabis-based medicine suppresses aversive memory and eases anxiety
Cannabis-based medicine PTSD treatments show promise in suppressing aversive memories and easing anxiety symptoms. Research indicates low doses can alleviate anxiety and facilitate fear memory extinction. This approach offers potential benefits for PTSD…
Cannabinoid receptor type 2 as a promising new target for schizophrenia drugs
Cannabinoid receptor type 2 schizophrenia roles are crucial in regulating symptoms like anxiety, depression, and cognitive impairments. This receptor influences various schizophrenia-related behaviors in animal models. Understanding CB2's impact offers…